longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Cue BioPharma

CUE

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | MOAT.US -0.89%, lighter-volume pullback

    Weekly Review·Sep 19 at 07:40 AM
    MOAT+0.29%
  • Weekly Recap | ARKG.US +13.35%, AI healthcare leads genomics theme

    Weekly Review·Sep 19 at 07:15 AM
    ARKG+2.05%
  • Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLab

    Weekly Review·Sep 19 at 06:54 AM
    TWST-0.74%
  • Weekly Recap | RXRX.US +19.69%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:40 AM
    RXRX+2.02%
  • Weekly Recap | Novavax +7.32%, outperforming the S&P 500

    Weekly Review·Sep 19 at 06:28 AM
    NVAX+4.03%
  • Weekly Recap | Medicinova +83.43%, most brokers rate it buy

    Weekly Review·Sep 19 at 06:26 AM
    MNOV-12.12%
  • Weekly Recap | LABU.US +0.73%, biotech ends mixed

    Weekly Review·Sep 19 at 06:14 AM
  • Weekly Recap | Cue BioPharma +4.74%, consensus target above spot

    Weekly Review·Sep 12 at 07:57 AM
    CUE+9.30%
  • Cue Biopharma (CUE) surges nearly 80% intraday

    Movers Alert·May 1 at 01:56 PM
    CUE+9.30%